Skip to main content
PolicySpeak
← All files
AU

Amsterdam UMC

Academic / research · Netherlands

not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.

3
positions filed
in the 665 files tracked
3
legislative files
of 665 tracked
2
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,800 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Track Amsterdam in PolicySpeak: request access →

Follow Amsterdam UMC

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at Amsterdam UMC? so we know who speaks for it.

Their record over time

Amsterdam UMC filed 3 positions between 18 May 2021 and 12 Nov 2025, across 3 of the 665 legislative files tracked here, attaching a full position paper 2 times.

2021 · 1 filed2023 · 1 filed2025 · 1 filed

What they argued

European Competitiveness Fundfiled 12 Nov 2025PDFsource

Explicit inclusion of European Reference Networks (ERNs) in the ECF is vital for health competitiveness and rare disease care The current proposal for the European Competitiveness Fund (ECF), specifically Chapter V (Articles 36 and 37) on Health, biotech, agriculture and bioeconomy, aligns perfectly with the mission of European Reference Networks (ERNs).

Medicinal products for human usefiled 14 Sept 2023PDFsource

Amsterdam UMCs response to the European Commission's pharmaceutical legislation proposal centers on three crucial aspects: "Market Exclusivity," "Drug Repurposing," and "Hospital Exemption." We advocate for a recalibration of market exclusivity durations to foster competition, the active engagement of academia in drug repurposing, and the removal of constraints on ATMP manufacturing and delivery for improved patient…

Electronic instructions for use for medical devicesfiled 18 May 2021source

Welcomes the fact that this will allow the manuals to be kept up to date, provided that the manufacturer/supplier stores them in a fixed digital place and is easily accessible to all parties (distributors and healthcare providers), as well as proper version management, so that customers can always have the latest version and quickly see the differences with older versions.

Filed in Dutch · English published by the European Commission

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Amsterdam UMC next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.

Showing 5 of 22.

Is this your organization?

Everything on this page comes from Amsterdam UMC’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.